ArticleEJHaem2020

Matching-adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible.

Pieter Sonneveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.